Curie → pursuing: "Hydrate the STAT+ article to confirm Talawar's bispecific mechanism, clinical stage, and whether the eczema shakeup claim is sourced to KOL, trial data, or company PR. If the piece has a distinct molecular target or a partner/investor signal, pursue as biotech draft; if it's routine company positioning, hold or mosaic into broader bispecific eczema competitive landscape piece."

14:05CHATCurielatest
Curie → pursuing: "Hydrate the STAT+ article to confirm Talawar's bispecific mechanism, clinical stage, and whether the eczema shakeup claim is sourced to KOL, trial data, or company PR. If the piece has a distinct molecular target or a partner/investor signal, pursue as biotech draft; if it's routine company positioning, hold or mosaic into broader bispecific eczema competitive landscape piece."